| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23155-550-31 | 23155-550 | HUMAN PRESCRIPTION DRUG | ONDANSETRON | ONDANSETRON | INJECTION | INTRAMUSCULAR; INTRAVENOUS | 20151109 | N/A | ANDA | ANDA090648 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ONDANSETRON HYDROCHLORIDE | 2 mg/mL | 1 VIAL in 1 CARTON (23155-550-31) / 20 mL in 1 VIAL |
| 23155-549-31 | 23155-549 | HUMAN PRESCRIPTION DRUG | ONDANSETRON | ONDANSETRON | INJECTION | INTRAMUSCULAR; INTRAVENOUS | 20120615 | N/A | ANDA | ANDA090648 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ONDANSETRON HYDROCHLORIDE | 2 mg/mL | 1 VIAL in 1 CARTON (23155-549-31) / 20 mL in 1 VIAL |
| 72266-124-01 | 72266-124 | HUMAN PRESCRIPTION DRUG | Ondansetron | Ondansetron | INJECTION | INTRAMUSCULAR; INTRAVENOUS | 20190402 | N/A | ANDA | ANDA090648 | Fosun Pharma USA Inc. | ONDANSETRON HYDROCHLORIDE | 2 mg/mL | 1 VIAL in 1 CARTON (72266-124-01) / 20 mL in 1 VIAL |
| 68083-114-01 | 68083-114 | HUMAN PRESCRIPTION DRUG | Ondansetron | Ondansetron | INJECTION | INTRAMUSCULAR; INTRAVENOUS | 20120615 | N/A | ANDA | ANDA090648 | Gland Pharma Limited | ONDANSETRON HYDROCHLORIDE | 2 mg/mL | 1 VIAL in 1 CARTON (68083-114-01) / 20 mL in 1 VIAL |
| 70860-777-21 | 70860-777 | HUMAN PRESCRIPTION DRUG | Ondansetron | ondansetron hydrochloride | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS | 20210215 | 20251130 | ANDA | ANDA090648 | Athenex Pharmaceutical Division, LLC. | ONDANSETRON HYDROCHLORIDE | 2 mg/mL | 10 VIAL, MULTI-DOSE in 1 CARTON (70860-777-21) / 20 mL in 1 VIAL, MULTI-DOSE |
符合检索条件的记录共 5 条，共 1 页，当前第 1 页 ，
可点击列名称排序
可点击列名称排序